Oruka Therapeutics (ORKA) EPS (Basic) Growth (1y) (2011 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,207.14% |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -80.00% |
| Mar 31, 2024 | -55.56% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 37.50% |
| Jun 30, 2023 | 54.55% |
| Mar 31, 2023 | 60.87% |
| Dec 31, 2022 | 80.00% |
| Sep 30, 2022 | 51.52% |
| Jun 30, 2022 | 35.29% |
| Mar 31, 2022 | 30.30% |
| Dec 31, 2021 | 34.43% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 53.42% |
| Mar 31, 2021 | 60.24% |
| Dec 31, 2020 | 11.59% |
| Sep 30, 2020 | 56.58% |
| Jun 30, 2020 | 35.96% |
| Mar 31, 2020 | 55.38% |
| Dec 31, 2019 | 64.06% |
| Sep 30, 2019 | 63.11% |
| Jun 30, 2019 | 58.39% |
| Mar 31, 2019 | 48.48% |
| Dec 31, 2018 | -464.71% |
| Sep 30, 2018 | -428.21% |
| Jun 30, 2018 | -364.41% |
| Mar 31, 2018 | -652.08% |
| Dec 31, 2017 | 26.09% |
| Sep 30, 2017 | 23.53% |
| Jun 30, 2017 | -37.21% |
| Mar 31, 2017 | -20.00% |
| Dec 31, 2016 | -64.29% |
| Sep 30, 2016 | -64.52% |
| Jun 30, 2016 | 37.68% |
| Mar 31, 2016 | 56.04% |
| Dec 31, 2015 | 67.82% |
| Sep 30, 2015 | 59.21% |
| Jun 30, 2015 | -527.27% |
| Mar 31, 2015 | -600.00% |
| Dec 31, 2014 | -987.50% |
| Sep 30, 2014 | -375.00% |
| Jun 30, 2014 | 83.08% |
| Mar 31, 2014 | 62.86% |
| Dec 31, 2013 | 72.41% |
| Sep 30, 2013 | 60.98% |
| Jun 30, 2013 | -14.04% |
| Mar 31, 2013 | 49.28% |
| Dec 31, 2012 | 89.75% |
| Sep 30, 2012 | -141.18% |
| Jun 30, 2012 | -2,000.00% |
| Mar 31, 2012 | -176.00% |
| Dec 31, 2011 | -1,472.22% |
| Sep 30, 2011 | 29.17% |
| Jun 30, 2011 | 111.54% |